Sort
46,585 grants matching “heart failure”
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
$782,932William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$782,809Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2023 · HL
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$782,809Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2022 · HL
Mitochondrial ATP Synthase in Cardiac Biology and Disease
$782,798Richard N Kitsis · Albert Einstein College Of Medicine · R01 · FY2022 · HL
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM
$782,727Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL
Atrial fibrillation ablation assessment and guidance using native-contrast T1 weighted MRI
$782,684Aravindan Kolandaivelu · Johns Hopkins University · R01 · FY2023 · HL
Atrial fibrillation ablation assessment and guidance using native-contrast T1 weighted MRI
$782,684Aravindan Kolandaivelu · Johns Hopkins University · R01 · FY2025 · HL
Atrial fibrillation ablation assessment and guidance using native-contrast T1 weighted MRI
$782,684Aravindan Kolandaivelu · Johns Hopkins University · R01 · FY2021 · HL
Investigating Donor Authorization and Public Perceptions of Normothermic Regional Perfusion to Inform Ethical Organ Donation Practices
$782,639Brendan Parent · New York University School Of Medicine · R01 · FY2024 · HL
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$782,512Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2022 · HL
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$782,500Kory J. Lavine · Washington University · R35 · FY2023 · HL
IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis
$782,464Gary K Owens · University Of Virginia · R01 · FY2019 · HL
A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients with Acute Heart Failure
$782,404Sean Patrick Collins · Vanderbilt University Medical Center · R33 · FY2025 · HL
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
$782,391Raymond Luke Comenzo · Tufts Medical Center · R01 · FY2025 · CA
Development of a TransApical to Aorta Double Lumen Cannula for a Neonate LVAD
$782,390Stephen R Topaz · W-Z Biotech, Llc · R44 · FY2019 · HL
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$782,326David Dale Thomas · University Of Minnesota · R01 · FY2020 · HL
Epidemiology of Depression and Heart Failure in Aging
$782,233Mary A Whooley · Northern California Institute/Res/Edu · R01 · FY2007 · HL
Precision Phenomics to Personalize Drug Therapy (P3DT)
$782,210Joshua C. Denny · Vanderbilt University Medical Center · P50 · FY2017 · GM
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
$782,126Abdullah Kutlar · Augusta University · R33 · FY2023 · HL
Occluded Artery Trial: Long Term Follow-Up
$782,108Judith S Hochman · New York University School Of Medicine · U01 · FY2008 · HL
Impact of Medically Tailored Meals on Obesity, Other Health Outcomes, and Healthcare Utilization under Medicaid Flexible Services
$782,037Dariush Mozaffarian · Tufts University Boston · R01 · FY2023 · DK
Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
$782,003Tellen Bennett · University Of Colorado Denver · R01 · FY2025 · HD
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$781,984Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2024 · AI
The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension
$781,934Andrea Lee Frump · Indiana University Indianapolis · R01 · FY2025 · HL
Nanostructuring and Molecular Imaging of Engineered Cardiovascular Tissues
$781,851Joseph C Wu · Stanford University · R33 · FY2011 · HL